Hepion Pharmaceuticals Interest Expense 2011-2026 | HEPA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Hepion Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	10.2 K	8.86 K	31.2 K	555 K	339 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
555 K	8.86 K	189 K

Quarterly Interest Expense Hepion Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	4.35 K	-	2.38 K	2.35 K	2.32 K	-	2.26 K	3.18 K	2.21 K	-	2.13 K	2.49 K	2.05 K	-	16.2 K	-	-	-	15.4 K	442 K	98.3 K	-	55.5 K	232 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
442 K	2.05 K	55.3 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	23 K	$ 21.87	2.15 %	$ 1.02 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	1.82 M	$ 22.67	3.23 %	$ 3.76 B	USA
Esperion Therapeutics ESPR	3.49 M	$ 2.02	5.5 %	$ 420 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Galectin Therapeutics GALT	1.03 M	$ 2.45	5.15 %	$ 157 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
Heron Therapeutics HRTX	1.34 M	$ 1.2	0.42 %	$ 200 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
ImmuCell Corporation ICCC	349 K	$ 8.24	-1.38 %	$ 74.4 M	USA
InflaRx N.V. IFRX	2.69 K	$ 1.52	2.36 %	$ 152 M	Germany
Brainstorm Cell Therapeutics BCLI	-93 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	14.2 M	$ 103.09	-2.25 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Innate Pharma S.A. IPHA	440 K	$ 1.36	-1.45 %	$ 235 M	France
Aquestive Therapeutics AQST	6.55 M	$ 4.17	2.21 %	$ 446 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 23.73	2.02 %	$ 3.02 B	USA
Inventiva S.A. IVA	12.2 M	$ 5.18	0.49 %	$ 138 M	France
Jaguar Health JAGX	67 K	$ 0.35	-9.42 %	$ 816 K	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.45	0.35 %	$ 386 M	Britain
KalVista Pharmaceuticals KALV	8.56 M	$ 20.06	2.18 %	$ 1.08 B	Britain
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.03	4.12 %	$ 4.99 M	Israel
BioDelivery Sciences International BDSI	-6 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Ligand Pharmaceuticals Incorporated LGND	-54.9 M	$ 233.96	1.16 %	$ 4.28 B	USA